GeoVax Labs GOVX
NASDAQ GOVX
$2.16 -0.52 (-19.28%)
At close: Nov 11, 2026 · 4:00 PM EST

GeoVax Labs (GOVX) Long-Term Debt Repayments (2019 - 2021)

Updated

GeoVax Labs' Long-Term Debt Repayments came in at $150,000 for FY2024.

Analysis

GeoVax Labs (GOVX) Long-Term Debt Repayments (2019 - 2021) Analysis & Trends

Going back to FY2019, GeoVax Labs' Long-Term Debt Repayments data covers 4 years.

  • Long-Term Debt Repayments carries a five-year compound annual growth rate of 71.0% (FY2019 to FY2024).
  • The FY2024 figure represents the lowest annual Long-Term Debt Repayments since FY2021.
  • Per Business Quant, earlier years put Long-Term Debt Repayments at $27,864 in FY2021 (+134.5%) and $11,880 in FY2020 (+15.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 GeoVax Labs 502,172.77 -12.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 24,801.00
Mar 31, 2021 3,063.00
Dec 31, 2020 3,026.00
Sep 30, 2020 2,988.00
Jun 30, 2020 1.20 Mn
Mar 31, 2020 2,914.00
Dec 31, 2019 1,924.00
Sep 30, 2019 3,124.00
Jun 30, 2019 3,126.00
Mar 31, 2019 2,083.00
API Access

GeoVax Labs Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=GOVX&period=max&api_key=YOUR_API_KEY